Design and synthesis of dual-target CDK9-EZH2 inhibitors using a pharmacophore fusion strategy.
- DOI
- 10.1016/j.bmcl.2026.130747
- Published
- 2026 Dec
- Container
- Bioorganic & medicinal chemistry letters
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmcl.2026.130747,
title = {Design and synthesis of dual-target CDK9-EZH2 inhibitors using a pharmacophore fusion strategy.},
author = {Han Y and Wang R and Tian L and Xiao J and Wei A and Ding J and Chen Y and Hu Y and Fang Y and Li X},
year = {2026},
journal = {Bioorganic \& medicinal chemistry letters},
doi = {10.1016/j.bmcl.2026.130747},
url = {https://doi.org/10.1016/j.bmcl.2026.130747}
}RIS
TY - JOUR TI - Design and synthesis of dual-target CDK9-EZH2 inhibitors using a pharmacophore fusion strategy. AU - Han Y AU - Wang R AU - Tian L AU - Xiao J AU - Wei A AU - Ding J AU - Chen Y AU - Hu Y AU - Fang Y AU - Li X PY - 2026 JO - Bioorganic & medicinal chemistry letters DO - 10.1016/j.bmcl.2026.130747 UR - https://doi.org/10.1016/j.bmcl.2026.130747 ER -
APA
Y, H., R, W., L, T., J, X., A, W., J, D., Y, C., Y, H., Y, F., & X, L. (2026). Design and synthesis of dual-target CDK9-EZH2 inhibitors using a pharmacophore fusion strategy.. Bioorganic & medicinal chemistry letters. https://doi.org/10.1016/j.bmcl.2026.130747
Source records
- pubmed · retrieved 2026-09-26T04:16:28.040Z